KRAS G12C inhibitors in KRASG12C-mutated solid tumors: an immunologically informed systematic review and reconstructed individual patient data meta-analysis - Poll - MDSpire

KRAS G12C inhibitors in KRASG12C-mutated solid tumors: an immunologically informed systematic review and reconstructed individual patient data meta-analysis

  • By

  • Yici Yan

  • Leyi Zheng

  • Hongfei Wang

  • Leitao Sun

  • Xing Xu

  • July 10, 2026

  • 0 min

Share

Original Source(s)

KRAS G12C inhibitors in KRASG12C-mutated solid tumors: an immunologically informed systematic review and reconstructed individual patient data meta-analysis

  • by Yici Yan, Leyi Zheng, Hongfei Wang, Leitao Sun, Xing Xu

  • July 10, 2026

Related Content

Telepresence avatar use for children with cancer in schools: a study on barriers and facilitators

Beyond AUC: a clinician’s guide to building and trusting prediction models in oncology—a narrative review

Inside the Rise of circRNA

Circio CEO Erik Wiklund reflects on the discovery of human circular RNA and its evolution into a fast-moving therapeutic modality

  • July 9, 2026

  • 12 min